Literature DB >> 1640867

Cortisol secretion in relation to body fat distribution in obese premenopausal women.

P Mårin1, N Darin, T Amemiya, B Andersson, S Jern, P Björntorp.   

Abstract

Urinary cortisol output and serum cortisol concentrations were measured in the steady state, under "field" conditions, and during standardized inhibitory and stimulatory tests in premenopausal, obese women, and were analyzed in relation to adipose tissue distribution. Urinary cortisol output was increased under field conditions in women with an elevated waist to hip circumference ratio (WHR) and, in particular, in women with a large abdominal sagittal diameter, indicating visceral fat accumulation. However, dexamethasone inhibition of cortisol secretion was normal. Stimulation with corticotropin analogue and with physical (cold-pressor test) or mental (color-word or mathematic) stress tests also showed elevated responses of serum cortisol, but not of prolactin or growth hormone concentrations. It is suggested that women with visceral fat accumulation have elevated cortisol secretion due to an increased sensitivity along the hypothalamic-pituitary-adrenal axis, and that this may be causing their abnormal fat depot distribution.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1640867     DOI: 10.1016/0026-0495(92)90171-6

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  89 in total

1.  Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome.

Authors:  A H Kissebah; G E Sonnenberg; J Myklebust; M Goldstein; K Broman; R G James; J A Marks; G R Krakower; H J Jacob; J Weber; L Martin; J Blangero; A G Comuzzie
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

2.  Affects and autonomic cardiac reactivity during experimentally induced stress as related to precursors of insulin resistance syndrome.

Authors:  Sampsa Puttonen; Liisa Keltikangas-Järvinen; Niklas Ravaja; Jorma Viikari
Journal:  Int J Behav Med       Date:  2003

Review 3.  Metabolic impact of body fat distribution.

Authors:  C Gasteyger; A Tremblay
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

Review 4.  Obesogens, stem cells and the developmental programming of obesity.

Authors:  A Janesick; B Blumberg
Journal:  Int J Androl       Date:  2012-02-28

5.  Obesity and the hypothalamic-pituitary-adrenal axis in adolescent girls.

Authors:  Jennifer B Hillman; Lorah D Dorn; Tammy L Loucks; Sarah L Berga
Journal:  Metabolism       Date:  2011-09-23       Impact factor: 8.694

6.  Decreased glucose tolerance and plasma adiponectin:resistin ratio in a mouse model of post-traumatic stress disorder.

Authors:  T R Castañeda; R Nogueiras; T D Müller; R Krishna; E Grant; A Jones; N Ottaway; G Ananthakrishnan; P T Pfluger; N Chaudhary; M B Solomon; S C Woods; J P Herman; M H Tschöp
Journal:  Diabetologia       Date:  2010-12-22       Impact factor: 10.122

Review 7.  Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism.

Authors:  Eliza B Geer; Julie Islam; Christoph Buettner
Journal:  Endocrinol Metab Clin North Am       Date:  2014-03       Impact factor: 4.741

Review 8.  Using animal models to study post-partum psychiatric disorders.

Authors:  C V Perani; D A Slattery
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

9.  The midnight-to-morning urinary cortisol increment method is not reliable for the assessment of hypothalamic-pituitary-adrenal insufficiency in patients with end-stage kidney disease.

Authors:  Y Oguz; C Oktenli; M Ozata; T Ozgurtas; Y Sanisoglu; M Yenicesu; A Vural; F Bulucu; I H Kocar
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

10.  Levels of maternal serum corticotropin-releasing hormone (CRH) at midpregnancy in relation to maternal characteristics.

Authors:  Yumin Chen; Claudia Holzman; Hwan Chung; Patricia Senagore; Nicole M Talge; Theresa Siler-Khodr
Journal:  Psychoneuroendocrinology       Date:  2009-12-16       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.